SKYRIZI 600 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

Abbvie Deutschland Gmbh & Co. Kg🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: fb52d1071111c4d1
Drug Cima Aemps Name: SKYRIZI 600 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1191361004
Holder Company Name: Abbvie Deutschland Gmbh & Co. Kg
Marketing Company Name: Abbvie Spain, S.L.U.
Holder Company Detail Path: /organization/abbvie-deutschland-gmbh-and-co-kg
Authorization Date: 2022-12-15
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 600 MG
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Abbvie Deutschland Gmbh & Co. Kg
Company Detail Path: /organization/abbvie-deutschland-gmbh-and-co-kg

RISANKIZUMAB

600 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 15, 2022

Approval ID

fb52d1071111c4d1

Type

Standard